Pomegranate juice and extracts lower inflammation, oxidative stress and free radical damage

The pomegranate is a gift from nature that provides powerful multi-modal health benefits. Extracts and the juice from this super fruit are shown to lower the damaging effects from systemic inflammation that are now associated with the development of many deadly diseases. Pomegranates have one of the highest antioxidant ORAC scores that help to neutralize the cellular and DNA damaging effects of free radicals that accelerate aging. Pomegranates are a tasty way to provide protection from the risk of developing many forms of cancer and cardiovascular and renal disease by regulating blood pressure and oxidized lipids.

Pomegranate in the Fight against Cancer Proliferation (more…)

Fight prostate cancer with pomegranates

Researchers from the University of California, Riverside, have identified yet another medicinal use for the pomegranate. According to Manuela Martins-Green, a professor of cell biology and author of the recent study, certain pomegranate compounds work to fight prostate cancer cells and prevent them from growing and spreading throughout the body. The findings support earlier work that has also identified the anti-cancer properties of pomegranates. (more…)

Low testosterone and aging

Environmental Medicine Doctor Chastised
Longtime environmental medicine expert Dr. William James Rea of Dallas, Texas, was disciplined by the Texas Medical Board at the end of August 2010.1 Rea has been a pioneer in developing techniques to diagnose and treat chemically and biologically sensitive patients. His clinic has focused on patients who are extremely sensitive to allergens, but not the allergens generally scrutinized by allergy specialists. Instead, Rea diagnoses sensitivity to petroleum and industrial chemicals, pesticides, and plasticizers, addressing the problem with strict protocols for avoidance of chemical exposure. Treatments do not rely on pharmaceuticals; instead, Rea administers desensitization therapies, usually in homeopathic dosing for the offending chemicals. In rare cases, patients are so sensitive that they need to be entirely removed from exposure to any chemicals. Rea, like other environmental medicine physicians, has advised some patients to confine themselves to special living units designed of plain metal and porcelain with fully filtered air and water.

Androgen Deprivation Therapy for Prostate Cancer Increases Risk of Colorectal Cancer.

Colon cancer also known as colorectal cancer starts in the colon (large intestine) or the rectum (end of the colon). With 655,000 deaths worldwide per year, it is the third most common form of cancer and the second leading cause of cancer-related death in the Western world. In the United States, it is the fourth most common cancer in men and women. Caught early, it is often curable. It is more common in people over 50, and the risk increases with age.

Male hormones are called androgens and primary among them is the natural hormone testosterone, which is produced in the testes, ovaries and adrenals. Hormone therapy also called androgen deprivation therapy (ADT) or androgen suppression therapy is used to reduce male hormones. Prostate cancer tends to shrink or grow more slowly when androgen levels are lowered but ADT does not cure the cancer. ADT is widely used in the community setting to treat men with clinically localized prostate cancer, prostate-specific antigen recurrence after radical prostatectomy, locally advanced disease, lymph node metastases, and asymptomatic metastatic disease.

A recent study published in the Journal of the National Cancer Institute found that men treated with hormone-based therapy (androgen deprivation) for prostate cancer had a significantly increased risk of colorectal cancer. The study included 107,859 men in the SEER-Medicare database who were diagnosed with prostate cancer between 1993 and 2002, who were followed up through 2004. The results revealed that men who received androgen deprivation therapy had a 30 to 40 percent increased risk of colorectal cancer when compared to those who did not receive hormone therapy. The researchers found that the longer men received hormone therapy, the higher their risk of developing colorectal cancer. Furthermore, men who had their testicles removed, a procedure called orchiectomy, had the highest rates of colorectal cancer. The risk of developing colorectal cancer was still low, at less that one percent per year, even among orchiectomy patients. This information suggests that while androgen deprivation is very beneficial to some men with advanced prostate cancer, it may not be the best therapy in cases when its benefit is not clear.1

1 Gillessen S, Templeton A, Marra G, et al. Risk of colorectal cancer in men on long-term androgen deprivation therapy for prostate cancer. J Natl Cancer Inst. Dec2010;102(23):1760-70.


Source: Journal of the National Cancer Institiute